High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
Permanent lenke
https://hdl.handle.net/10037/21805Dato
2021-01-06Type
Journal articleTidsskriftartikkel
Peer reviewed
Forfatter
Estaleva, Calvina E.L.; Zimba, Tomas F.; Sekyere, John Osei; Govinden, Usha; Chenia, Hafizah Y.; Simonsen, Gunnar S.; Haldorsen, Bjørg; Essack, Sabiha Y.; Sundsfjord, ArnfinnSammendrag
Background: Epidemiological data of cephalosporin-resistant Enterobacterales in Sub-Saharan Africa is still restricted,and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum β-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical strains of Escherichia coli at Maputo Central Hospital (MCH), a 1000-bed reference hospital in Maputo, Mozambique.
Methods: A total of 230 clinical isolates of E. coli from urine (n = 199) and blood cultures (n = 31) were collected at MCH during August–November 2015. Antimicrobial susceptibility testing was performed by the disc diffusion
method and interpreted according to EUCAST guidelines. Isolates with reduced susceptibility to 3rd generation
cephalosporins were examined further; phenotypically for an ESBL−/AmpC-phenotype by combined disc methods
and genetically for ESBL- and pAmpC-encoding genes by PCR and partial amplicon sequencing as well as genetic
relatedness by ERIC-PCR.
Results: A total of 75 isolates with reduced susceptibility to cefotaxime and/or ceftazidime (n = 75) from urine (n = 58/199; 29%) and blood (n = 17/31; 55%) were detected. All 75 isolates were phenotypically ESBL-positive and 25/75
(33%) of those also expressed an AmpC-phenotype. ESBL-PCR and amplicon sequencing revealed a majority of
blaCTX-M (n = 58/75; 77%) dominated by blaCTX-M-15. All AmpC-phenotype positive isolates (n = 25/75; 33%) scored
positive for one or more pAmpC-genes dominated by blaMOX/FOX. Multidrug resistance (resistance ≥ three antibiotic classes) was observed in all the 75 ESBL-positive isolates dominated by resistance to trimethoprimsulfamethoxazole, ciprofloxacin and gentamicin. ERIC-PCR revealed genetic diversity among strains with minor clusters indicating intra-hospital spread.
Conclusion: We have observed a high prevalence of MDR pAmpC- and/or ESBL-producing clinical E. coli isolates
with FOX/MOX and CTX-Ms as the major β-lactamase types, respectively. ERIC-PCR analyses revealed genetic
diversity and some clusters indicating within-hospital spread. The overall findings strongly support the urgent need for accurate and rapid diagnostic services to guide antibiotic treatment and improved infection control measures.
Forlag
BMCSitering
Estalva, Zimba, John, Simonsen GS, Haldorsen BC, Essack S, Sundsfjord A. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique. BMC Infectious Diseases. 2021;21(18)Metadata
Vis full innførselSamlinger
Copyright 2021 The Author(s)